BY THE OPTIMIST DAILY EDITORIAL TEAM A global trial discovered a potential new medicine combination that prevents lung cancer progression for much longer than existing standard therapies. The combination of amivantamab and lazertinib increased progression-free survival in patients with advanced Read More...